Robert James Wills, Director at Oncternal Therapeutics, Inc. (ONCT), bought 13,828 shares at $8.48 ($117K) on 2024-03-28, disclosed to the SEC on 2024-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.48 | 6,914 | $59K | 50.0% |
| 2 | $8.48 | 6,914 | $59K | 50.0% |
| Total | $8.48 avg | 13,828 | $117K | 100% |
| Filing → |
| ONCT | BUY | 2024-04-10 | $28K | — | Filing → |
| ONCT | SELL | 2024-02-27 | $9K | — | Filing → |
| MIST | BUY | 2022-10-21 | $74K | — | Filing → |